Potassium chloride and Dacogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium chloride (potassium chloride) and Dacogen (decitabine). Common drug interactions include thrombocytopenia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium chloride and Dacogen. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium chloride?

Potassium chloride has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 29,249 Potassium chloride users. Check the latest studies of Potassium chloride.

What is Dacogen?

Dacogen has active ingredients of decitabine. eHealthMe is studying from 1,541 Dacogen users. Check the latest studies of Dacogen.

On Jul, 14, 2026

11 people who take Potassium chloride and Dacogen together, and have interactions are studied.

Potassium chloride and Dacogen drug interactions.

What are the common drug interactions of Potassium Chloride and Dacogen, by gender? *:

female:

Thrombocytopenia (decrease of platelets in blood)
Alanine aminotransferase increased
Anaemia (lack of blood)
Aspartate aminotransferase increased
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Febrile neutropenia (fever with reduced white blood cells)
Haemorrhage (bleeding)

male:

Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Hospitalisation
Joint swelling
Nausea (feeling of having an urge to vomit)
Peripheral swelling
Pyrexia (fever)
Skin exfoliation (removal of the oldest dead skin cells)
Skin hyperpigmentation (disorders affect the colour of your skin)
White blood cell count increased

What are the common drug interactions of Potassium Chloride and Dacogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Dry eye (lack of adequate tears)
Febrile neutropenia (fever with reduced white blood cells)
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)
Skin exfoliation (removal of the oldest dead skin cells)
Skin hyperpigmentation (disorders affect the colour of your skin)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Thrombocytopenia (decrease of platelets in blood)
Alanine aminotransferase increased
Diarrhoea
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Dyspnoea (difficult or laboured respiration)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Fall
Febrile neutropenia (fever with reduced white blood cells)
Haemorrhage (bleeding)
Joint swelling

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 63.64%
Purpura (purplish discoloration of the skin): 2 people, 18.18%
Multiple Myeloma (cancer of the plasma cells): 2 people, 18.18%
Epstein-Barr Virus Infection: 2 people, 18.18%
Bleeding Disorders: 2 people, 18.18%
Anaemia Of Chronic Disease: 2 people, 18.18%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 9.09%
Nausea (feeling of having an urge to vomit): 1 person, 9.09%
Depression: 1 person, 9.09%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium chloride and Dacogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously